Commentary: Novartis CEO: Gene therapy offers hope of cures in a treatment, but US needs new pricing, payment model

The current global health system treats chronic diseases with a pay-as-you-go model, spreading costs over months and years. It's unprepared to pay for a surge of new, single-treatment therapies with the potential to provide a lifetime of benefit. Health and … Read more…

Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday

The congressional hearing sets up a potentially hostile showdown between Washington and drugmakers, who face the threat of legislative action after years of setting drug prices in the U.S. without serious repercussions. Health and Science U.S.HEALTHCARE UPDATE: Click today to … Read more…